Please login to the form below
legislation
This page shows the latest legislation news and features for those working in and with pharma, biotech and healthcare.
Moderna looks to price COVID-19 vaccine at $50-$60 per course
Last week, US president Donald Trump signed four executive orders targeting drug prices, including new legislation allowing states, wholesalers and pharmacies to import FDA-approved medicines from foreign countries and sell
Latest news
-
UK government considers move into ‘delay’ phase of coronavirus response plan
The measures could also introduce emergency legislation which would allow people to volunteer to work in the NHS or care homes, while safeguarding their usual day jobs, in an attempt to
-
House Democrats finally pass landmark drug pricing bill
Proposed legislation met with harsh criticism from pharma industry. After much tweaking and negotiation, a drug pricing bill backed by House Speaker Nancy Pelosi was passed in the US in a ... The first versions of the legislation were leaked in September,
-
Four digital health trends set to reinvent and re-energise pharma
evolve. Meanwhile, companies must ensure that even where legislation hasn’t yet kept up with developments, they remain on the right side of the ethical line without incurring unnecessary costs.
-
Another day, another Brexit delay – so what happens now?
to enforce EU legislation there but possibly divergent UK rules on the mainland, said BIA chief executive Steve Bates.
-
It's the guns, stupid
We know it is a multi- factorial public health issue that has roots in mental illness and a pervasive culture of violence, along with lax gun legislation that allows access to
UK government considers move into ‘delay’ phase of coronavirus response plan
House Democrats finally pass landmark drug pricing bill
Four digital health trends set to reinvent and re-energise pharma
Another day, another Brexit delay – so what happens now?
It's the guns, stupid
More from news
Approximately 0 fully matching, plus 403 partially matching documents found.
Latest Intelligence
-
Piloting a route to the biosimilars opportunities in Europe
The US market also has a lot of interest in creating cohesive guidelines and legislation around biosimilars interchangeability, something that is still lacking from the EMA.
-
EU cross-border healthcare
The current EU framework is composed of two pieces of legislation which each lay out a different, but equally complex, patient journey: The ‘Directive on Patients’ Rights in Cross-Border Healthcare’
-
Now that COVID-19 vaccines have been approved, it’s our turn, healthcare communicators
We must be equipped to react if, and when, new legislation offers new opportunity.
-
How can virtual pharma companies de-risk new product launches?
Compliance is a vastly general term because pharmaceutical manufacture and distribution are so heavily regulated, and there are globally accepted best practice standards and national legislation requirements that differ by region.
-
The US celebrates five years of biosimilars on the market – a look to the past, present and future
In Medicare Part B, legislation could be passed to encourage physician adoption of biosimilars through a temporary increase in reimbursement and reduced cost sharing for beneficiaries.
Piloting a route to the biosimilars opportunities in Europe
EU cross-border healthcare
Now that COVID-19 vaccines have been approved, it’s our turn, healthcare communicators
How can virtual pharma companies de-risk new product launches?
The US celebrates five years of biosimilars on the market – a look to the past, present and future
More from intelligence
Approximately 2 fully matching, plus 80 partially matching documents found.
Latest appointments
-
Portland Health appoints Jamie Hewitt as an account director
During his time at the National Rheumatoid Arthritis Society, Hewitt ran UK campaigns to increase access to medicines, raise disease awareness and influence legislation on health, social care and welfare reform.
-
Sonia Ruiz Moran appointed president of EMVO
in order to prevent falsified medicines from reaching patients, in accordance with EU legislation.”.
-
Red Door boosts digital team
Kharbanda has also been a policy adviser in the European Parliament, advising an MEP on EU healthcare legislation and political communications. .
-
Spectrum appoints Dr Dalna Harvey as regulatory project manager
In her new role Dr Harvey will will be responsible for updating Spectrum's global healthcare clients on legislation amendments, providing strategic and technical advice and maintaining marketing authorisations.
-
EMA's Dr Stella Blackburn joins Quintiles
group. . The development and commercial services group said Dr Blackburn's new role would see her assist with areas such as the interpretation of pharmacovigilance legislation and ensuring regulatory compliance. .
Portland Health appoints Jamie Hewitt as an account director
Sonia Ruiz Moran appointed president of EMVO
Red Door boosts digital team
Spectrum appoints Dr Dalna Harvey as regulatory project manager
EMA's Dr Stella Blackburn joins Quintiles
More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest from PMHub
-
What do NHS changes and the Life Sciences Vision mean for medicines?
With the publication of a new Life Sciences Vision (LSV), the first major piece of health legislation in nine years and a new Health Secretary and NHS England Chief Executive, there
-
How does the government plan to reshape the NHS?
Integrated care. The white paper confirms that NHS England (NHSE) is backing legislation to abolish Clinical Commissioning Groups (CCGs).
-
WHITE PAPER: What's missing in women's health?
GOV UK. 2019. No. 990. http://www.legislation.gov.uk/uksi/2019/990/made. Published June 7, 2019. Accessed May 4, 2020.
-
Rare Disease Day – why it’s important to show your stripes
A standardised definition for rare diseases is currently lacking, with incidences typically defined by regional legislations developed to incentivise drug development (termed ‘orphan medicines/drugs’ by the FDA and EMA).
-
It's out - so what?
That is when the Commission’s proposal – or proposals – to revise the basic EU pharmaceutical legislation will be published. ... This is not just a question of tweaking a piece of legislation here or changing a delegated act there.
What do NHS changes and the Life Sciences Vision mean for medicines?
WHITE PAPER: What's missing in women's health?
Rare Disease Day – why it’s important to show your stripes
More from PMHub
Approximately 2 fully matching, plus 23 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Digital account director
-
Competitive
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital strategist
-
Competitive
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital project manager
-
Competitive
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- GSK reveals plans for £400m R&D facility expansion in England
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med
- Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Pharma’s authentic proof of purpose influences decisions among HCPs and payers
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
